CPCamila Pantoja-Ruiz

Camila Pantoja-Ruiz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Camila Pantoja-Ruiz has a total of 88 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Frailty Index Progression Around Hypertension Diagnosis in 14 Countries

    by Dongfeng Tang, Aicha Goubar, Camila Pantoja-Ruiz, Ajay Bhalla, Julie Whitney, Miao Cai, Wuquan Deng, Shangfeng Tang, Iain J. Marshall, Charles D.A. Wolfe, et al.

    BACKGROUND: Hypertension and frailty frequently coexist in older adults. However, relationships between their trajectories are unclear. This study aims to examine whether frailty progressed differently between individuals with and without hypertension before and after diagnosis. METHODS: Data were drawn from 3 nationally representative cohorts across 14 countries, including 21 418 participants (mean baseline age 63.2±10.2 years) followed for 16 to 18 years. Individuals with hypertension at baseline were excluded. Hypertension was defined by self-reported physician diagnosis and antihypertensive medication use by self-report of taking any medication. Diagnosis timing was based on the first survey wave at which hypertension was reported. Coarsened exact matching matched participants who developed hypertension with those who did not. Piecewise linear mixed models estimated frailty trajectories before and after diagnosis. RESULTS: Among 10 709 participants who developed hypertension (median diagnosis age 70 years), frailty index rescaled to a 0 to 100 scale (0–100) increased by 0.63 points/y (95% CI, 0.57–0.70) before diagnosis and 1.09 points/y (95% CI, 0.97–1.21) after diagnosis. During the 8 years preceding diagnosis, participants who developed hypertension experienced greater increases in frailty index rescaled to a 0 to 100 scale than matched controls without hypertension (difference, 2.69 [95% CI, 2.43–2.95]). The corresponding difference during the 8 years after diagnosis was 1.51 (95% CI, 1.01–2.01). Among individuals with hypertension, antihypertensive medication use was associated with a nonsignificant reduction in frailty progression after diagnosis. Findings remained robust after excluding participants with cardiovascular conditions. CONCLUSIONS: Participants with hypertension experienced faster frailty progression before and after diagnosis. Studies using objective blood pressure measurement are needed to confirm this association.

  • Open Access

    Ataxic variant of sporadic Creutzfeldt-Jakob disease with predominant basal ganglia involvement: Case report and review of molecular classification and their MRI patterns

    by Lussiana Folleco-Insuasty, Camila Pantoja-Ruiz, Elkin García-Cifuentes, Catalina Cerquera-Cleves, Adriana Casallas-Vanegas

    Introduction: Creutzfeldt-Jakob disease (CJD) is a rare, rapidly progressive neurodegenerative di­sorder caused by the accumulation of misfolded prion proteins. Molecular classification, based on PRNP codon 129 polymorphisms and the protease-resistant PrPsc fragment, has refined recogni­tion of subtypes and their correlation with specific neuroimaging patterns. Case presentation: We report a 60-year-old patient presenting with progressive instability, late­ral propulsion, generalized polymyoclonus, tremors, paranoid delusions, and vivid hallucinations. Prominent cerebellar signs and gait disturbance were dominant, configuring an ataxic phenotype accompanied by cognitive decline. An extensive workup excluded alternative diagnoses, and the de­tection of 14-3-3 protein in cerebrospinal fluid, along with positive RT-QuIC and diffusion-wei­ghted magnetic resonance imaging (MRI) findings, were compatible with probable sporadic CJD. Remarkably, the MRI revealed an atypical pattern with predominant basal ganglia involvement rather than the common cortical changes, raising MV2K as a radiological hypothesis and underscoring the clinical-radiological heterogeneity of the ataxic presentation. Discussion: CJD has diverse phenotypic variants. Molecular classification and advanced MRI tech­niques, particularly diffusion-weighted imaging (DWI), are crucial for distinguishing between spo­radic subtypes. Identifying atypical presentations, such as ataxic variants with basal ganglia pre­dominance, improves premortem diagnostic certainty in resource-limited settings where molecular subtyping is not widely available. Conclusion: Molecular and neuroimaging-based approaches have substantially deepened the un­derstanding of CJD heterogeneity. This case emphasizes the value of DWI/MRI in identifying atypi­cal ataxic variants and reinforces the importance of integrating biomarker-supported diagnosis and clinical-radiological correlation when approaching this disease.

  • Open Access

    National impact of ICD-11 stroke reclassification on projected incidence across the United Kingdom

    by Camila Pantoja-Ruiz, Eva S Emmett, Evelyn Lim, Wasana Kalansooriya, Sophie Rowland-Coomber, Svetlana Mamac, Tayla Schaapveld, Abdel Douiri, Julia Fox-Rushby, Yanzhong Wang, et al.

    The ICD-11 stroke definition expands stroke diagnosis by including neuroimaging-confirmed brain lesions regardless of symptom duration. Using directly age- and sex-standardized rates from the South London Stroke Register applied to UK Census 2021/2022 populations, we projected that ICD-11 to increase UK stroke incidence by ∼4.2%, yielding an estimated 2771 additional cases annually (England +2313; Scotland +241; Wales +142; Northern Ireland +75). Ethnicity-adjusted estimates suggested a 6.2% increase for England and Wales. These projections are scenario estimates that assume South London rates apply uniformly across the UK, their central limitation, and their realization will depend on local imaging and referral practice. Many additional cases will likely be managed in outpatient settings, requiring expanded provision, improved MRI, and strengthened cardiovascular prevention.

  • Open Access

    Temporal Trends and Drivers of Socioeconomic Inequalities in Stroke Care, Survival, and Long‐Term Outcomes

    by Eva S. Emmett, Camila Pantoja‐Ruiz, Abdel Douiri, David Wyatt, Martin Chapman, Wasana Kalansooriya, Julia Fox‐Rushby, Amal R. Khanolkar, Yanzhong Wang, Ajay Bhalla, et al.

    Background: Stroke disproportionately affects individuals with lower socioeconomic status (SES). This study investigates socioeconomic inequalities in stroke care and long‐term outcomes since 1995. Methods: Using the South London Stroke Register (1995–2024), SES was measured at the area‐level (Index of Multiple Deprivation [IMD]) and individual‐level (occupation). Associations between SES and stroke unit admission, thrombolysis, and poststroke disability (Barthel Index/0–14), dependency (Frenchay Activities Index/0–15), and depression (Hospital Anxiety and Depression Scale/8–21) were estimated using multivariable logistic regression; and SES‐effect on 5‐year survival was estimated using Kaplan‐Meier and Cox Proportional‐hazard models. Results: A total of 7714 participants were included (median age [interquartile range]: 70.9 years [59.0–80.8 years]; women: N=3677 [47.7%]). SES was not associated with stroke unit admission (IMD 1 (most deprived) versus IMD 3/4/5 (least deprived): odds ratio 0.90 [95% CI 0.76–1.08]; routine/manual versus nonroutine/nonmanual occupation: 1.04 [0.92–1.17]) or thrombolysis (0.91 [0.66–1.25]; 0.94 [0.75–1.16], respectively). Poorer survival of participants with lower SES in 1995 to 2003 (IMD 1 versus IMD 3/4/5: hazard ratio 2.24 [95% CI 1.81–2.76]; routine/manual versus nonroutine/nonmanual: 1.09 [0.98–1.24]) was not observed in 2013 to 2022 (1.02 [0.82–1.26]; 0.97 [0.82–1.15]). A total of 3944 completed 3‐month (64.8% of alive) and 2364 5‐year follow‐ups (69.4%). In stroke‐year/age/sex‐adjusted analyses, participants with lower SES persistently experienced higher rates of 3‐month and 5‐year disability and dependency and 5‐year depression. Further adjustments for ethnicity, vascular risk factors, stroke type/severity and acute interventions had minor attenuating effects. Conclusions: Access to key acute interventions was equitable and the survival disadvantage of participants with lower SES declined. Persistent inequalities in functional and mental health outcomes might be driven by factors beyond acute interventions (eg, rehabilitation access or post‐acute social support), requiring integrated care approaches addressing clinical and social determinants of stroke recovery.

  • Open Access

    Ethnic Inequalities in Return to Work Post First Stroke: Findings From a Population‐Based Cohort Study in South London

    by Amal R. Khanolkar, Ajay Bhalla, Eva Emmett, Camila Pantoja‐Ruiz, Charles D. A. Wolfe, Matthew D. L. O'COnnell, Iain J. Marshall

    Background: Return to work post stroke is affected by sociodemographic factors and disability. We explored ethnic differences in employment among White, Black African, Black Caribbean, and other ethnic minority groups at 1 and 5 years post first stroke in a population‐based cohort. Methods: Data on individuals with first‐ever stroke were obtained from the South London Stroke Register ([SLSR] patients registered between 1995 and 2025). Analysis was restricted to individuals in employment at the time of first stroke (N=1737, 67% men, mean age: 54 years [SD: 12.1]), with employment status assessed at 1 year and 5 years follow‐up. Associations between ethnicity and employment status (employed, retired or other) were examined using multinomial logistic regression adjusting for a range of sociodemographic (age, sex, study period, socioeconomic deprivation) and clinical factors (eg, stroke severity and management, co‐occurring health conditions, functional indicators) at baseline and follow‐up. Results: After adjusting for baseline factors (socioeconomic deprivation/stroke severity/health conditions), Black African (relative risk ratio [RRR] 0.47 [95% CI 0.29–0.75]) and Black Caribbean (RRR, 0.40, [0.22–0.75]) groups were significantly less likely to be employed at 1 year post stroke than White individuals. At 5 years, only Black African individuals were less likely to be employed (RRR, 0.59 [95% CI, 0.30–1.15]). Similar ethnic disparities were observed at 1 year and 5 years in relation to clinical factors assessed at follow‐up. Conclusions: Black survivors of stroke were ~50% less likely to be employed 1 year after stroke compared with White survivors, with Black African disadvantage persisting at 5 years after stroke. These persistent disparities were not explained by sociodemographic, stroke severity, and functional/health indicators. More research is required to better understand what drives the ethnic disparities in poststroke return to work.

  • Impact of ICD-11 Stroke Definition on Incidence and Outcomes

    by Camila Pantoja-Ruiz, Eva S. Emmett, Ajay Bhalla, Abdel Douiri, Yanzhong Wang, David Wyatt, Wasana Kalansooriya, Martin Chapman, Julia Fox-Rushby, C.D.A. Wolfe, et al.


  • Open Access

    Widening Ethnic Inequalities in Stroke Incidence: A 30-Year Population-Based Analysis of the South London Stroke Register

    by Camila Pantoja-Ruiz, Amal R. Khanolkar, Ismail Ismail, Aliya Almirova, Evelyn Lim, Marina Soley-Bori, Wasana Kalansooriya, Eva S. Emmett, Abdel Douiri, David Wyatt, et al.

    Aim/background: Ethnic inequalities in stroke incidence are well-established, but long-term trends and the impact of socioeconomic status (SES) remain understudied. We estimated incidence rates by ethnicity over 30-years, and differences by SES, using the South London Stroke Register (1995–2024). Methods: We conducted a population-based study including all residents of a geographically defined area of South London, calculating standardised incidence rates using census-derived denominators and the 2013 European Standard Population. The area-level Index of Multiple Deprivation was the indicator of SES. Poisson regression estimated incidence rate ratios comparing ethnic-minority vs White groups, adjusting for age, sex, and SES, with ethnicity-SES interaction testing and marginal rates derived by subgroup. Results: Among 7,726 people with first-ever stroke, overall standardised incidence decreased 34% between 1995–1999 and 2010–2014 (198;[187.8–208] to 131;[122.4–138.9] per 100,000), then increased 13% in 2020–2024. Black-African and Black-Caribbean populations had higher baseline incidence persisting across all periods. Ethnic inequalities narrowed initially but subsequently widened, with incidence twice as high in Black-African (IRR=2.31;[2.03–2.62]) and Black-Caribbean (IRR=2.00;[1.73–2.31]) groups compared to White groups in 2020–2024. Patterns were consistent across stroke subtypes, with the largest inequalities in primary intracerebral haemorrhage. Ethnic differences in incidence attenuated on SES adjustment but remained significant. Within ethnic groups, most deprived Black-African and Black-Caribbean populations showed highest incidence. Conclusion: Stroke incidence has risen sharply in the past five years, driven by rising incidence rates in Black-African and Black-Caribbean populations, with reduction in the White population. Achieving equity requires ensuring uptake of cardiovascular risk programmes across all socioeconomic and ethnic groups, with earlier risk management for groups who develop stroke 10-12 years younger than the general population.

  • Open Access

    A systematic review of causal pathways of socioeconomic inequalities in stroke

    by Camila Pantoja-Ruiz, Lu Liu, Evelyn Lim, Marina Soley-Bori, Wasana Kalansooriya, Eva Emmett, Abdel Douiri, Yanzhong Wang, Ajay Bhalla, Amal R Khanolkar, et al.

    Background: Socioeconomic status (SES), often measured by education, income, occupation, or area-level deprivation, impacts stroke incidence and outcomes, yet the underlying mechanisms remain unclear. This review synthesizes causal analyses quantifying drivers of these inequalities. Methods: We conducted a systematic review (PROSPERO CRD42024554285) and reported following the PRISMA-2020 guidelines. Observational studies applying causal mediation analysis between SES and stroke risk, disability, or mortality were included from PubMed, Embase, Scopus, and Google Scholar. SES indicators, outcomes, mediators, and decompositions into natural direct effect (NDE) and natural indirect effect (NIE) were extracted. Risk of bias and certainty of evidence were assessed using ROBINS-E and GRADE. A narrative synthesis was undertaken, and findings were illustrated in causal diagrams. Results: Of 12,034 records, 19 studies (15 in high-income countries) were included. Lower SES increased stroke incidence through hypertension (NIE 14–21% of the total effect, moderate certainty), although one study restricted to women reported smaller effects (2–4%). Smoking (6–19.9%, very low certainty). At 3 months post-stroke, the combined outcome of death or disability was higher due to severe strokes (38.5% for ischemic, 57–94% for hemorrhagic, moderate certainty). One study found that hypertension, atrial fibrillation, and smoking together mediated 28.5% of the SES effect on stroke severity (low certainty). Reduced access to thrombolysis and stroke units mediated 2.7% of 3-month disability/mortality (very low certainty), while greater distance to specialized centers explained 48% of inequalities in thrombectomy access (low certainty). Long-term mortality (⩾6 months) was mediated by comorbidities (18%) and healthcare coverage (24–55%), both with low certainty. Conclusions: Hypertension, smoking, and differential stroke severity at presentation are the main pathways through which low SES increases stroke risk and causes worse outcomes. Targeting these may reduce inequalities, though evidence from low-income settings and emerging mediators (e.g. early-life SES, environmental exposures, care quality) is lacking.


  • Open Access

    Prevalence and patterns of comorbidities in individuals with epilepsy: A nationwide analysis using colombian healthcare registry data

    by Camila Pantoja-Ruiz, Carmela Fawcett, Isabela Lacouture, Hannia Barrios, Daniel Nariño, Diego Rosselli


  • Top Cited Papers
    Open Access

    Socioeconomic Status and Stroke: A Review of the Latest Evidence on Inequalities and Their Drivers

    by Camila Pantoja-Ruiz, Rufus Akinyemi, Diego I. Lucumi-Cuesta, Daniel Youkee, Eva Emmett, Marina Soley-Bori, Wasana Kalansooriya, Charles Wolfe, Iain J. Marshall

    The latest research on socioeconomic status (SES) and stroke continues to demonstrate that individuals with low SES are at a higher risk of stroke, receive lower-quality care, and experience poorer outcomes. Despite growing evidence on the impact of SES on stroke, gaps remain in understanding the underlying mechanisms and the influence of SES in different contexts, particularly in low- and middle-income countries. This narrative review builds upon our previous reviews from 2006 to 2015, focusing on studies published since 2015 to update on the influence of SES on stroke. Reports from nationwide or population-based observational studies in the past decade have confirmed that these inequalities persist globally and have provided new evidence on their mechanisms. In high-income countries, inadequate control of cardiovascular risk factors (hypertension, diabetes, obesity, and dyslipidemia) among lower socioeconomic groups has been found to explain much of the inequality in stroke risk. Exposure to particulate air pollution (both environmental and indoor from solid fuel cooking) synergizes with cardiovascular risk factors, especially hypertension, as major causes in low- and middle-income countries. Lower SES is persistently associated with disparities in care and increased poststroke disability and mortality. Lower SES also exacerbates other causes of health inequality among women, ethnic minorities, and migrants. Addressing stroke inequalities requires an interdisciplinary approach. Targeting cardiovascular risk factors, providing equitable quality of acute and rehabilitative stroke care, enacting legislative measures, and implementing societal changes remain leading global priorities.